Ascendis Pharma A ASND
NASDAQ ASND
$228.07 -1.98 (-0.86%)
At close: Sep 29, 2026 · 4:00 PM EDT

Ascendis Pharma A (ASND) EV to EBIT (2026)

Updated

Ascendis Pharma A's (ASND) EV to EBIT was 50.33 for the quarter ended Jun 30, 2026.

Analysis

Ascendis Pharma A (ASND) EV to EBIT (2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Ascendis Pharma A's EV to EBIT came in at 41.26.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 Ascendis Pharma A 14.26 Bn 10.50 Bn 362.22 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 50.33
API Access

Ascendis Pharma A EV to EBIT API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-ebit&ticker=ASND&period=max&api_key=YOUR_API_KEY